EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, Molecular Docking, and Anticancer Activity of Chalcone Derivatives as VEGFR-2 Inhibitors

Mingjun Yu iD, Xin Zhang iD, Hui Zhu, Xiaoqian Zhang

Molecules · 24.11.2025 · 30 (23) · 4526

DOI: 10.3390/molecules30234526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 24.11.2025. Verfasst von Mingjun Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Bozhou University, Bozhou 236800, China. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents, Drug Design, Chalcones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bozhou University Research Initiation Program, Bozhou University Enterprise Cooperation Project, Bozhou University Teaching Reform Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 4-phenylurea chalcones (2a–2s) as VEGFR-2 inhibitors has been designed, synthesized, and evaluated for in vitro cytotoxic activity against K562, SiHa, and B16 cancer cells. Compared to sorafenib, the compounds exhibited strong cytotoxicity against K562, SiHa and B16 cells. Compounds 2r, 2o, and 2l exhibited remarkable cytotoxicity against K562, SiHa, and B16 cells, with IC50 values of 0.97 μM, 1.22 μM, and 1.39 μM, respectively. Moreover, compound 2l exhibited potent cytotoxicity against K562, SiHa, and B16, with IC50 values ranging from 1.25 μM to 1.39 μM. Compounds 2l and 2o also exhibited excellent inhibitory activity on VEGFR-2 kinase, with IC50 values of 0.42 ± 0.03 and 0.31 ± 0.02 μM, respectively. Molecular docking proved that the target compounds had strong binding interactions with VEGFR-2 proteins. Flow cytometry analysis showed that compound 2l induced apoptosis and arrested the cell cycle at the G1 and S phases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsDrug DesignChalconesProtein Kinase InhibitorsChalconeMolecular Docking SimulationHumansCell Line, TumorApoptosisStructure-Activity RelationshipCell ProliferationDrug Screening Assays, AntitumorMolecular StructureAnimals

Stichwörter der Autor:innen

VEGFR-2anticancerchalconemolecular dockingurea fragment

Substanzen

Vascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsChalconesProtein Kinase InhibitorsKDR protein, humanChalcone

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Bozhou University, Bozhou 236800, China.
  • School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong SAR 999077, China.

ORCID-Profile: Mingjun Yu, Xin Zhang

Förderung

  • Bozhou University Research Initiation Program
  • Bozhou University Enterprise Cooperation Project
  • Bozhou University Teaching Reform Program
  • Anhui Province University Science and Engineering Teachers' Internship Program in Enterprises
  • Anhui Province University Science and Engineering Teachers’ Internship Program in Enterprises

Zitieren

APA

Yu, M., Zhang, X., Zhu, H., & Zhang, X. (2025). Design, Synthesis, Molecular Docking, and Anticancer Activity of Chalcone Derivatives as VEGFR-2 Inhibitors. Molecules, 30(23), 4526. https://doi.org/10.3390/molecules30234526

Vancouver

Yu M, Zhang X, Zhu H, Zhang X. Design, Synthesis, Molecular Docking, and Anticancer Activity of Chalcone Derivatives as VEGFR-2 Inhibitors. Molecules. 2025;30(23):4526. doi:10.3390/molecules30234526

BibTeX
@article{Yu2025,
  author = {Yu, Mingjun and Zhang, Xin and Zhu, Hui and Zhang, Xiaoqian},
  title = {Design, Synthesis, Molecular Docking, and Anticancer Activity of Chalcone Derivatives as VEGFR-2 Inhibitors},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {23},
  pages = {4526},
  doi = {10.3390/molecules30234526}
}
Kostenlos starten →